CD47 and neoplasm: In addition, the expression of CD47 on normal tissues may create an ‘antigen sink’ that prevents anti-CD47 therapeutic antibodies from reaching tumor cell targets in vivo, which also pose a problem in the development of anti-CD47 bsAbs.